Effects of Loigolactobacillus coryniformis K8 CECT 5711 on the Immune Response of Elderly Subjects to COVID-19 Vaccination: A Randomized Controlled Trial
2022; Multidisciplinary Digital Publishing Institute; Volume: 14; Issue: 1 Linguagem: Inglês
10.3390/nu14010228
ISSN2072-6643
AutoresAnxo Fernández‐Ferreiro, Francisco Javier Formigo Couceiro, Roi Veiga-Gutierrez, Jose A. Maldonado-Lobón, Ana M. Hermida-Cao, Carlos Rodríguez, Óscar Bañuelos, Mónica Olivares, Ruth Blanco-Rojo,
Tópico(s)vaccines and immunoinformatics approaches
ResumoElderly people are particularly vulnerable to COVID-19, with a high risk of developing severe disease and a reduced immune response to the COVID-19 vaccine. A randomized, placebo-controlled, double-blind trial to assess the effect of the consumption of the probiotic
Referência(s)